Trump reportedly plans to fire FDA Commissioner Marty Makary

Reports have emerged that President Trump is contemplating the dismissal of Food and Drug Administration Commissioner Marty Makary. However, sources indicate that this decision is not yet finalized and may still change. This information was first revealed by insiders to The Wall Street Journal, with further confirmation from Bloomberg, The Washington Post, and Politico. The potential removal of Makary follows a challenging year marked by significant turmoil within the FDA. The agency has faced numerous controversies, including issues related to personnel, vaccine approvals, gene therapy decisions, and regulatory oversight of abortion pills and vaping products. Recently, it was reported that Trump expressed frustration with Makary for his slow pace in approving flavored vapes and nicotine products, which the administration views as pivotal to their campaign promise to support vaping. Specifically, it has been reported that Makary delayed the approval of menthol, mango, and blueberry vape flavors due to concerns they could attract younger individuals to vaping. This week, following pressure from Trump, the FDA moved forward with the approval of these flavors. Within the administration, officials have viewed Makary as struggling to effectively lead the FDA and have noted conflicts with other health officials. Complaints from the pharmaceutical industry have also surfaced regarding his leadership. Should Makary be removed from his position, it would add to the growing list of vacancies in key health agencies, which are currently overseen by Health Secretary Robert F. Kennedy Jr., who has been criticized for his anti-vaccine stance. The FDA, the Centers for Disease Control and Prevention, and the National Institutes of Health have experienced a significant exodus of leadership during the Trump administration, leaving the CDC without a director and the public health sector in a state of uncertainty.